Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second leading cause of cancer mortality worldwide. The cornerstone to improving the prognosis of HCC patients has been the control of loco-regional disease progression and the lesser toxicities of local treatment. Although r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Che-Yu, Wang, Chun-Wei, Cheng, Ann-Lii, Kuo, Sung-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700034/
https://www.ncbi.nlm.nih.gov/pubmed/31435460
http://dx.doi.org/10.4251/wjgo.v11.i8.579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700034/
https://www.ncbi.nlm.nih.gov/pubmed/31435460
http://dx.doi.org/10.4251/wjgo.v11.i8.579

Ejemplares similares